Annual EBITDA:
-$677.70M-$199.82M(-41.82%)Summary
- As of today, RVMD annual EBITDA is -$677.70 million, with the most recent change of -$199.82 million (-41.82%) on December 31, 2024.
- During the last 3 years, RVMD annual EBITDA has fallen by -$497.95 million (-277.03%).
- RVMD annual EBITDA is now -2171.42% below its all-time high of -$29.84 million, reached on December 31, 2017.
Performance
RVMD EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$260.91M-$23.87M(-10.07%)Summary
- As of today, RVMD quarterly EBITDA is -$260.91 million, with the most recent change of -$23.87 million (-10.07%) on June 30, 2025.
- Over the past year, RVMD quarterly EBITDA has dropped by -$107.07 million (-69.59%).
- RVMD quarterly EBITDA is now -2711.55% below its all-time high of -$9.28 million, reached on June 30, 2019.
Performance
RVMD Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$883.71M-$107.07M(-13.79%)Summary
- As of today, RVMD TTM EBITDA is -$883.71 million, with the most recent change of -$107.07 million (-13.79%) on June 30, 2025.
- Over the past year, RVMD TTM EBITDA has dropped by -$293.54 million (-49.74%).
- RVMD TTM EBITDA is now -8225.14% below its all-time high of -$10.62 million, reached on December 31, 2018.
Performance
RVMD TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
RVMD EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -41.8% | -69.6% | -49.7% |
| 3Y3 Years | -277.0% | -336.6% | -306.8% |
| 5Y5 Years | -1294.8% | -919.9% | -905.7% |
RVMD EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -277.0% | at low | -341.4% | at low | -268.0% | at low |
| 5Y | 5-Year | -1294.8% | at low | -920.2% | at low | -905.7% | at low |
| All-Time | All-Time | -2171.4% | at low | -2711.6% | at low | -8225.1% | at low |
RVMD EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$260.91M(-10.1%) | -$883.71M(-13.8%) |
| Mar 2025 | - | -$237.04M(-11.3%) | -$776.65M(-14.6%) |
| Dec 2024 | -$677.70M(-41.8%) | -$212.92M(-23.2%) | -$677.70M(-5.6%) |
| Sep 2024 | - | -$172.84M(-12.3%) | -$641.90M(-8.8%) |
| Jun 2024 | - | -$153.85M(-11.4%) | -$590.17M(-8.6%) |
| Mar 2024 | - | -$138.10M(+22.0%) | -$543.35M(-13.7%) |
| Dec 2023 | -$477.88M(-92.2%) | -$177.13M(-46.3%) | -$477.88M(-32.8%) |
| Sep 2023 | - | -$121.10M(-13.2%) | -$359.86M(-15.0%) |
| Jun 2023 | - | -$107.02M(-47.4%) | -$312.86M(-17.8%) |
| Mar 2023 | - | -$72.62M(-22.9%) | -$265.59M(-6.8%) |
| Dec 2022 | -$248.62M(-38.3%) | -$59.11M(+20.2%) | -$248.62M(-3.5%) |
| Sep 2022 | - | -$74.10M(-24.0%) | -$240.13M(-10.5%) |
| Jun 2022 | - | -$59.76M(-7.4%) | -$217.22M(-8.7%) |
| Mar 2022 | - | -$55.66M(-10.0%) | -$199.92M(-11.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$179.75M(-76.4%) | -$50.61M(+1.1%) | -$179.75M(-11.5%) |
| Sep 2021 | - | -$51.19M(-20.6%) | -$161.26M(-18.9%) |
| Jun 2021 | - | -$42.46M(-19.6%) | -$135.65M(-14.2%) |
| Mar 2021 | - | -$35.49M(-10.5%) | -$118.77M(-16.5%) |
| Dec 2020 | -$101.91M(-109.7%) | -$32.13M(-25.6%) | -$101.91M(-16.0%) |
| Sep 2020 | - | -$25.57M(+0.0%) | -$87.87M(-18.4%) |
| Jun 2020 | - | -$25.58M(-37.3%) | -$74.21M(-28.2%) |
| Mar 2020 | - | -$18.63M(-3.0%) | -$57.91M(-19.2%) |
| Dec 2019 | -$48.59M(-21.7%) | -$18.08M(-51.7%) | -$48.59M(-18.2%) |
| Sep 2019 | - | -$11.92M(-28.4%) | -$41.12M(-40.8%) |
| Jun 2019 | - | -$9.28M(+0.3%) | -$29.20M(-46.6%) |
| Mar 2019 | - | -$9.31M(+12.3%) | -$19.92M(-87.7%) |
| Dec 2018 | -$39.91M(-33.8%) | -$10.62M | -$10.62M |
| Dec 2017 | -$29.84M | - | - |
FAQ
- What is Revolution Medicines, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Revolution Medicines, Inc.?
- What is Revolution Medicines, Inc. annual EBITDA year-on-year change?
- What is Revolution Medicines, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Revolution Medicines, Inc.?
- What is Revolution Medicines, Inc. quarterly EBITDA year-on-year change?
- What is Revolution Medicines, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Revolution Medicines, Inc.?
- What is Revolution Medicines, Inc. TTM EBITDA year-on-year change?
What is Revolution Medicines, Inc. annual EBITDA?
The current annual EBITDA of RVMD is -$677.70M
What is the all-time high annual EBITDA for Revolution Medicines, Inc.?
Revolution Medicines, Inc. all-time high annual EBITDA is -$29.84M
What is Revolution Medicines, Inc. annual EBITDA year-on-year change?
Over the past year, RVMD annual EBITDA has changed by -$199.82M (-41.82%)
What is Revolution Medicines, Inc. quarterly EBITDA?
The current quarterly EBITDA of RVMD is -$260.91M
What is the all-time high quarterly EBITDA for Revolution Medicines, Inc.?
Revolution Medicines, Inc. all-time high quarterly EBITDA is -$9.28M
What is Revolution Medicines, Inc. quarterly EBITDA year-on-year change?
Over the past year, RVMD quarterly EBITDA has changed by -$107.07M (-69.59%)
What is Revolution Medicines, Inc. TTM EBITDA?
The current TTM EBITDA of RVMD is -$883.71M
What is the all-time high TTM EBITDA for Revolution Medicines, Inc.?
Revolution Medicines, Inc. all-time high TTM EBITDA is -$10.62M
What is Revolution Medicines, Inc. TTM EBITDA year-on-year change?
Over the past year, RVMD TTM EBITDA has changed by -$293.54M (-49.74%)